EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudieOpen Access · CC BY 4.0

Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment

Henrike Meyer iD, Andreas Hinz, Christiane Weisgerber, Adrian Pilny, Nadja Dornhöfer, Anja Mehnert-Theuerkauf, Bahriye Aktas, Benjamin Wolf

Archives of Gynecology and Obstetrics · 2024

DOI: 10.1007/s00404-024-07886-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Henrike Meyer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany. Hauptthemen laut MEDLINE: Lymphedema, Genital Neoplasms, Female, Patient Reported Outcome Measures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Leipzig.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The Gynecologic Cancer Lymphedema Questionnaire (GCLQ) is an established patient-reported outcome measure for lower extremity lymphedema (LEL) in gynecologic oncology. We aimed to validate the GCLQ in German language (GCLQ-GER) for lymphedema detection in German-speaking patients and also investigated real-world patterns of lymphedema treatment.

Methods

The GCLQ was translated from English into German in accordance with the standards of a professional translation process. Subsequently, the questionnaire was administered in a prospective observational study including 102 patients who had undergone lymph node dissection (LND) within gynecologic cancer surgery. Various test quality criteria were calculated for the GCLQ-GER. As gold standard of testing methods, patients were clinically evaluated for LEL, and limb volume measurements were taken. Further data for lymphedema treatment were collected in patients with lymphedema diagnosis.

Results

Patients with LEL had increased GCLQ-GER total scores (mean 7.27) compared to patients without LEL (mean 1.81), p < 0.001. High diagnostic accuracy was indicated by the large area under the receiver operating characteristics curve (AUC) of 0.874 (95% CI 0.802–0.946). Based on sensitivity and specificity values ≥ 79.0%, the GCLQ total score ≥ 4 was determined as the optimal cut-off value to identify LEL. Excellent internal consistency was demonstrated by Cronbach’s alpha of 0.876. The clinical examination revealed a LEL prevalence of 48.0% (n = 49), and 85.7% (n = 42) of these patients received treatment.

Conclusion

The GCLQ-GER is a valid and feasible patient-reported outcome measure for lymphedema detection in German-speaking gynecologic cancer survivors. Its clinical introduction could improve secondary prevention of lymphedema and real-world treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphedemaGenital Neoplasms, FemalePatient Reported Outcome MeasuresHumansFemaleMiddle AgedLower ExtremityProspective StudiesSurveys and QuestionnairesAgedLymph Node ExcisionAdultGermanyLanguageTranslations

Stichwörter der Autor:innen

Clinical screening toolGCLQ-GERPatient-reported outcome measures (PROMs)Quality of lifeSecondary prevention of lymphedema

Autor:innen und Institutionen

  • Department of Gynecology, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany.
  • Department of Medical Psychology and Medical Sociology, Comprehensive Cancer Center Central Germany (CCCG), University Medical Center Leipzig, Leipzig, Germany.
  • Department of Gynecology, University Hospital Leipzig, Liebigstraße 20a, 04103, Leipzig, Germany. benjamin.wolf@medizin.uni-leipzig.de.
  • Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA. benjamin.wolf@medizin.uni-leipzig.de.

ORCID-Profile: Henrike Meyer

Förderung

  • Universitätsklinikum Leipzig

Zitieren

APA

Meyer, H., Hinz, A., Weisgerber, C., Pilny, A., Dornhöfer, N., Mehnert-Theuerkauf, A., Aktas, B., & Wolf, B. (2024). Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07886-4

Vancouver

Meyer H, Hinz A, Weisgerber C, Pilny A, Dornhöfer N, Mehnert-Theuerkauf A, et al. Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07886-4

BibTeX
@article{Meyer2024,
  author = {Meyer, Henrike and Hinz, Andreas and Weisgerber, Christiane and Pilny, Adrian and Dornhöfer, Nadja and Mehnert-Theuerkauf, Anja and Aktas, Bahriye and Wolf, Benjamin},
  title = {Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  doi = {10.1007/s00404-024-07886-4}
}
Kostenlos starten →